SCHEMBL19720600

SCHEMBL19720600

COC(=O)c1cc(C#N)c2c(c1)nc(N=NN)n2C1CCCCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CHEK2 O96017 2/20 0.36
▸ NSD2 O96028 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ BTK Q06187 1/20 0.34
▸ EHMT2 Q96KQ7 1/20 0.34
▸ GPR119 Q8TDV5 4/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ JAK2 O60674 2/20 0.34
▸ JAK1 P23458 2/20 0.34
▸ USP30 Q70CQ3 2/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ UCHL1 P09936 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19190253 0.89 ALDH1A1 (0.38) ALDH1A1MEN1MAPTKMT2ACHEK2
SCHEMBL16895750 0.81 MEN1 (0.39) ALDH1A1MEN1MAPTKMT2ACHEK2
SCHEMBL16896132 0.78 EGFR (0.57) —
SCHEMBL16901742 0.77 MEN1 (0.40) ALDH1A1MEN1MAPTKMT2ACHEK2
SCHEMBL19720567 0.77 BTK (0.36) ALDH1A1MEN1KMT2ACHEK2BTK
SCHEMBL19720598 0.76 MEN1 (0.37) ALDH1A1MEN1MAPTKMT2APIK3CD
SCHEMBL19720620 0.75 MEN1 (0.35) ALDH1A1MEN1MAPTKMT2ACHEK2
SCHEMBL16903327 0.72 USP30 (0.42) ALDH1A1MEN1MAPTKMT2ANSD2
SCHEMBL16895972 0.70 RPS6KB1 (0.49) ALDH1A1CHEK2L3MBTL1BTKSCN9A
SCHEMBL16895971 0.70 RPS6KB1 (0.49) ALDH1A1CHEK2L3MBTL1BTKSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3257848-A1 COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR ACTIVITY Novartis AG (CH) 2017-12-20 — — EP disclosed
Send feedback